1. Home
  2. NTRA vs EQT Comparison

NTRA vs EQT Comparison

Compare NTRA & EQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • EQT
  • Stock Information
  • Founded
  • NTRA 2003
  • EQT 1925
  • Country
  • NTRA United States
  • EQT United States
  • Employees
  • NTRA N/A
  • EQT N/A
  • Industry
  • NTRA Medical Specialities
  • EQT Oil & Gas Production
  • Sector
  • NTRA Health Care
  • EQT Energy
  • Exchange
  • NTRA Nasdaq
  • EQT Nasdaq
  • Market Cap
  • NTRA 18.4B
  • EQT 20.4B
  • IPO Year
  • NTRA 2015
  • EQT N/A
  • Fundamental
  • Price
  • NTRA $148.08
  • EQT $50.98
  • Analyst Decision
  • NTRA Strong Buy
  • EQT Buy
  • Analyst Count
  • NTRA 17
  • EQT 18
  • Target Price
  • NTRA $176.65
  • EQT $55.82
  • AVG Volume (30 Days)
  • NTRA 1.6M
  • EQT 9.2M
  • Earning Date
  • NTRA 05-08-2025
  • EQT 04-22-2025
  • Dividend Yield
  • NTRA N/A
  • EQT 1.24%
  • EPS Growth
  • NTRA N/A
  • EQT N/A
  • EPS
  • NTRA N/A
  • EQT 0.45
  • Revenue
  • NTRA $1,696,911,000.00
  • EQT $5,041,956,000.00
  • Revenue This Year
  • NTRA $15.33
  • EQT $64.92
  • Revenue Next Year
  • NTRA $18.50
  • EQT $11.46
  • P/E Ratio
  • NTRA N/A
  • EQT $113.73
  • Revenue Growth
  • NTRA 56.75
  • EQT 1.36
  • 52 Week Low
  • NTRA $83.13
  • EQT $30.02
  • 52 Week High
  • NTRA $183.00
  • EQT $56.66
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 50.83
  • EQT 51.10
  • Support Level
  • NTRA $125.38
  • EQT $49.57
  • Resistance Level
  • NTRA $152.66
  • EQT $51.94
  • Average True Range (ATR)
  • NTRA 8.82
  • EQT 2.78
  • MACD
  • NTRA 1.47
  • EQT -0.02
  • Stochastic Oscillator
  • NTRA 82.19
  • EQT 63.44

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About EQT EQT Corporation

EQT Corp is an independent natural gas production company with operations focused in the cores of the Marcellus and Utica shales in the Appalachian Basin, located in the Eastern United States. The firm focuses on executing combo-development projects for developing multiwell pads to meet supply needs, with a focus on maximizing operational efficiency, technology, and sustainability. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has one reportable segment and its revenue stems from three types of gas reserves: natural gas, natural gas liquids, and crude oil. All of the firm's operating revenue is generated in the U.S., with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.

Share on Social Networks: